Skip to main content
. Author manuscript; available in PMC: 2009 Jan 26.
Published in final edited form as: Hum Antibodies. 2005;14(3-4):101–113.

TABLE 2. Analysis of serum neutralization mechanism.

Neutralization activity of various plasma against JR-FL-based VLPs was analyzed in various formats. As in Table 1, neutralization formats are organized in columns. IC50 data are given as reciprocal plasma dilutions. Neutralization has been color-coded in a similar manner to Table 1. N.D.=not done. JR-FL gp120 ELISA titers for each serum against gp120 are shown. IC50 data not shown in the table for plasmas N308, A62, L909, and TN15 were 4,000, 300, 170 and 67, respectively against gp160WT-VLPs in the standard format and 15,000, 3,000, 150 and 99 against gp160ΔCT WT-VLPs in the standard format.

column 1 2 3
format standard post-CD4 post-CD4/CCR5
WT/SOS WT SOS
IC50 titer: human plasma gp120 titer
<50 N308 250,000 9,000 240,000 <40
50-300 A62 100,000 2,000 89,600 <40
300-1000 #11H 500,000 1,000 90,000 <40
1000-3000 L92 1,000,000 400 500,000 <40
>3000 L909 1,500,000 320 309,000 <40
R2 600,000 150 500,000 <40
739 80,000 100 200,000 <40
TN15 603,000 64 143,000 40
J864 248,000 50 84,000 <40
N160 500,000 <40 160,000 <40
K370 381,000 <40 100,000 <40
TN11 119,000 <40 19,000 <40
L503 612,000 <40 162,000 <40
HIV- <300 <40 250 <40
spiked human plasma
J864 248,000 50 84,000 <40
J864+b12 N.D. 950 90,000 <10
J864+2G12 N.D. 120 80,000 <10
J864+2F5 N.D. 110 82,000 71